Are chimeric antigen receptor T cells ready for prime time?

Clin Adv Hematol Oncol. 2016 Jan;14(1):17-9.
No abstract available

MeSH terms

  • Antibodies, Monoclonal / genetics*
  • Antibodies, Monoclonal / immunology*
  • Clinical Trials as Topic
  • Genetic Engineering
  • Humans
  • Immunotherapy / adverse effects
  • Immunotherapy / methods
  • Leukemia, Lymphocytic, Chronic, B-Cell / immunology
  • Leukemia, Lymphocytic, Chronic, B-Cell / therapy
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / immunology
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy
  • Receptors, Antigen, T-Cell / genetics*
  • Receptors, Antigen, T-Cell / metabolism*
  • Recombinant Fusion Proteins*
  • T-Lymphocytes / immunology*
  • T-Lymphocytes / metabolism*
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Receptors, Antigen, T-Cell
  • Recombinant Fusion Proteins